Group 1: Core Insights - Rongchang Biologics (09995.HK) announced that its innovative drug Taitasip (brand name: Tai Ai®) for treating primary Sjögren's syndrome has met the primary endpoint in a Phase III clinical trial in China [1] - Taitasip is the first BLyS/APRIL dual-target fusion protein drug to complete Phase III research in the field of Sjögren's syndrome globally [1] - The clinical trial was a multi-center, randomized, double-blind, placebo-controlled study aimed at evaluating the efficacy and safety of Taitasip, with the primary endpoint being the change in ESSDAI score at week 24 compared to baseline [1] Group 2: Disease Background and Drug Mechanism - Sjögren's syndrome is a chronic inflammatory autoimmune disease characterized by lymphocytic infiltration and damage to exocrine glands, leading to persistent dry mouth and dry eyes, and can affect multiple organ systems [2] - The prevalence of Sjögren's syndrome in China is estimated to be between 0.3% and 0.7%, with an increasing trend indicating a significant unmet clinical need [2] - Taitasip is a novel dual-target fusion protein developed by the company that simultaneously inhibits the overexpression of BLyS and APRIL, effectively preventing abnormal differentiation and maturation of B cells [2] Group 3: Regulatory and Clinical Recognition - Taitasip has received multiple authoritative guideline recommendations in China, including the "Clinical Practice Guidelines for Sjögren's Syndrome" and the "Expert Consensus on B-cell Targeted Therapy for Rheumatic and Immune Diseases" [2] - Internationally, Taitasip has been granted Fast Track designation by the U.S. FDA for its indication in Sjögren's syndrome and has been approved to conduct global multi-center Phase III clinical trials [2]

Core Viewpoint - The company anticipates a revenue increase for the first half of 2025, but expects to report a significant loss compared to the previous year [1] Revenue Expectations - The company expects to achieve revenue of approximately 10.4 billion to 10.5 billion yuan, representing a year-on-year increase of 4.2% to 5.2% [1] - Overseas revenue is projected to be around 140 million to 150 million yuan, with a substantial year-on-year increase of 273.3% to 300.0% [1] Loss Projections - The company anticipates a total loss attributable to shareholders and comprehensive expenses of approximately 65 million to 72 million yuan, marking a shift from profit to loss [1] - The expected loss for the six months ending June 30, 2025, is estimated to be around 680 million to 700 million yuan, compared to a loss of 346 million yuan in the same period last year [1]

Core Viewpoint - The company, Mengjinyuan (02585), anticipates a revenue of approximately 10.4 billion to 10.5 billion yuan for the first half of 2025, representing a year-on-year increase of 4.2% to 5.2% [1] Revenue Expectations - The expected overseas revenue is around 140 million to 150 million yuan, showing a significant year-on-year increase of 273.3% to 300.0% [1] Profit and Loss Forecast - The company projects a total loss attributable to shareholders and comprehensive expenses of approximately 65 million to 72 million yuan, indicating a shift from profit to loss compared to the previous year [1] - The anticipated loss is primarily due to increased losses from Au(T+D) contracts and gold leasing, with a comparison to a loss of 346 million yuan in the same period last year [1] - The expected total loss for the six months ending June 30, 2025, is estimated to be around 680 million to 700 million yuan [1]

Group 1 - The company expects total revenue for the six months ending June 30, 2025, to be between RMB 10,400 million and RMB 10,500 million, representing a year-on-year increase of 4.2% to 5.2% compared to RMB 9,979.7 million for the six months ending June 30, 2024 [1] - The overseas revenue for the same period is projected to be between RMB 140 million and RMB 150 million, a significant increase of 273.3% to 300.0% compared to RMB 37.5 million for the six months ending June 30, 2024 [1] - The company anticipates a loss attributable to shareholders for the six months ending June 30, 2025, ranging from RMB 65 million to RMB 72 million, a substantial decrease of 237.1% to 251.9% compared to a profit of RMB 47.4 million for the same period in 2024 [1][2] Group 2 - The expected transition from profit to loss is primarily due to increased losses from Au(T+D) contracts and gold leasing, with total losses projected to be between RMB 680 million and RMB 700 million for the six months ending June 30, 2025, compared to a loss of RMB 345.7 million for the same period in 2024 [2] - The company engages in Au(T+D) contracts solely to hedge against gold price fluctuations and does not engage in speculative activities as defined by Hong Kong Financial Reporting Standard No. 9 [2] - The company plans to implement measures to mitigate the adverse effects of short-term gold price increases, aiming to sell products at prices above the average procurement cost, while closely monitoring market acceptance of rising gold prices [3]

Group 1 - The company, Mengjinyuan (02585.HK), will hold a board meeting on August 26, 2025 [1] - The agenda includes reviewing and approving the group's interim results for the six months ending June 30, 2025, and discussing the proposal for an interim dividend, if any [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損 失承擔任何責任。 (i) 截至2025年6 月30日止六個月的收益介乎人民幣10,400 百萬元至人民幣10,500 百萬元， 對 比 截 至 2024 年 6 月 30 日 止 六 個 月 的 總 收 益 人 民 幣 9,979.7 百 萬 元 ， 同 比 增 加 4.2% 至 5.2%； (ii) 截至2025年6月30日止六個月的海外收益介乎人民幣140百萬元至人民幣150百萬元，對 比 截 至 2024 年 6 月 30 日 止 六 個 月 的 海 外 收 益 人 民 幣 37.5 百 萬 元 ， 同 比 增 加 273.3% 至 300.0%；及 (iii) 截至2025年6月30日止六個月的本公司擁有人應佔期內虧損及全面開支總額介乎人民幣 65百萬元至人民幣72百萬元，對比截至2024年6月30日止六個月的本公司擁有人應佔期 內溢利及全面收益總額人民幣47.4百萬元，同比減少237.1%至251.9%。 夢 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損 失承擔任何責任。 MOKINGRAN JEWELLERY GROUP CO., LTD. 夢 金 園 黃 金 珠 寶 集 團 股 份 有 限 公 司 （ 於中華人民共和國註冊成立的股份有限公司） （股份代號：2585） 承董事會命 MOKINGRAN JEWELLERY GROUP CO., LTD. 夢金園黃金珠寶集團股份有限公司 董事長兼執行董事 王忠善 山東，中華人民共和國 2025年8月14日 於本公告日期，董事會包括執行董事王忠善先生、張秀芹女士、王國鑫先生及王澤鋼先生；及獨立非執行董 事白顯月先生、翁欣先生及丁曉東先生。 董事會會議日期 夢 金 園 黃 金 珠 寶 集 團 股 份 有 限 公 司（「 本 公 司 」）董 事 會（「 董 事 會」）謹 此 宣 佈 ， 本 公 司 將 於 2025年8月26日（ 星期二 ）舉行董事會會議，藉以（ 其中包括 ）審議及批准本公司及其附屬公 司截至2025年6月30日止 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 夢金園黃金珠寶集團股份有限公司 呈交日期: 2025年8月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02585 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 233,023,466 | RMB | | | 1 RMB | | 233,023,466 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 233,023,466 | RMB | | | 1 RMB | | 233,023,466 | | 2. 股份分 ...

Financial Performance - Total revenue decreased by 2.5% to RMB 19,712.9 million compared to RMB 20,208.6 million in 2023[7] - Net profit for the year was RMB 200.7 million, down from RMB 233.5 million in 2023, with basic earnings per share at RMB 0.81 compared to RMB 1.01 in 2023[7] - The gross profit for 2024 was RMB 1,330.9 million, representing a gross margin of 6.8%, up from 5.3% in 2023[17] - The net profit attributable to equity shareholders for 2024 was RMB 189.4 million, down from RMB 230.4 million in 2023, with a profit margin of 1.0%[17] - Total comprehensive income for the year was RMB 200.7 million, reflecting a 14.0% decline compared to the previous year[48] - Profit before tax decreased by 11.6% to RMB 269.8 million, mainly due to increased realized losses from Au (T+D) contracts[46] Revenue Sources - Overseas revenue reached RMB 140.3 million, a significant increase of 701.7% from RMB 17.5 million in 2023[10] - Sales revenue from gold jewelry and other gold products was RMB 19,280.2 million, down 3.0% from RMB 19,877.4 million in 2023[25] - K-gold jewelry and diamond-studded products saw revenue increase to RMB 342.7 million, a growth of 52.0% compared to RMB 225.5 million in 2023[26] - E-commerce sales revenue surged to RMB 2,017.1 million, an increase of 168.7% from RMB 750.7 million in 2023, contributing 10.2% to total revenue[31] Operational Changes - The company established a franchise network with 2,758 stores, a decrease from 2,817 stores in 2023, and operated 33 self-owned stores, down from 35[8] - The company plans to open multiple new stores in key development areas in 2025 to enhance brand image and market coverage[11] - The company has established a franchise network covering 2,758 franchise stores as of December 31, 2024[22] Research and Development - The company holds 660 patents, including 47 invention patents and 115 utility model patents, reflecting a strong focus on R&D[10] - Research and development expenses increased to RMB 22.4 million, a rise of 28.0% from RMB 17.5 million in 2023[39] Financial Position - The total assets increased to RMB 4,934.7 million in 2024, compared to RMB 4,021.0 million in 2023[17] - Trade receivables increased by 83.7% to RMB 276.4 million, attributed to extended credit terms offered to selected franchisees[52] - Cash and cash equivalents rose significantly to RMB 556.2 million, up from RMB 155.9 million, primarily due to unutilized proceeds from the global offering[55] - The group's interest-bearing borrowings increased to RMB 1,348.9 million as of December 31, 2024, compared to RMB 790.0 million in 2023, primarily for general operational needs[66] Corporate Governance - The board proposed a final dividend of RMB 0.30 per share (before tax)[7] - The proposed final dividend is subject to approval at the annual general meeting scheduled for May 16, 2025, with an expected distribution date no later than two months after the meeting[118] - The company has complied with corporate governance codes as detailed in the annual report[137] Market Trends and Risks - The group faces various market risks, including commodity price risk, interest rate risk, and economic development changes[75] - The company’s business growth is dependent on consumer demand for its products, which may be affected by market trends and consumer preferences[117] - Fluctuations in raw material prices may adversely affect the company's business and financial performance[117] Sustainability and ESG Initiatives - The company emphasizes a commitment to sustainable development and ethical business practices, integrating these principles into its operations[195] - The group is committed to sustainable development, actively implementing measures to manage emissions and reduce resource consumption[197] - The group has established a comprehensive ESG governance structure, integrating ESG management into strategic decision-making and daily operations[196] Employee and Management Information - The company had 1,884 full-time employees as of December 31, 2024, a decrease from 1,997 in 2023[144] - Employee welfare expenses, excluding director and supervisor remuneration, amounted to RMB 245.5 million, down from RMB 249.7 million in 2023[144] - The company continues to invest in employee training programs to enhance overall efficiency and employee engagement[145]

Core Viewpoint - The approval of H-share full circulation for Mengjinyuan marks a significant expansion of the company's financing channels, but it faces challenges in the consumer market due to quality issues and increased competition [2][22]. Company Performance - Mengjinyuan's revenue from 2021 to 2024 showed fluctuations: 168.71 billion, 157.24 billion, 202.09 billion, and 197.1 billion respectively, with a 2.5% decline in 2024 compared to the previous year [15]. - The net profit for the same period was 2.25 billion, 1.81 billion, 2.34 billion, and 1.89 billion respectively, indicating a 17.8% decrease in 2024 [16]. Consumer Complaints - Mengjinyuan has faced numerous consumer complaints regarding product quality, including issues of selling fake gold, concealing weight, and quality defects [4][6]. - Specific complaints include incidents where customers received less gold than promised during exchanges and issues with product durability, such as rings deforming and earrings discoloring shortly after purchase [11][13]. Market Challenges - The company is experiencing challenges in its primary market of lower-tier cities, where competitors like Chow Tai Fook and Chow Sang Sang are rapidly expanding their presence [17][18]. - Mengjinyuan's franchise store count has decreased, with a net reduction of 59 stores in 2024, contrasting with competitors' aggressive growth strategies [18]. Industry Dynamics - The rise of the "Shuibei model," which allows wholesalers to sell directly to consumers at lower prices, is eroding Mengjinyuan's competitive pricing advantage [19]. - Young consumers are increasingly favoring unique designs and brand culture, which Mengjinyuan's traditional product offerings do not adequately address [20][21]. Strategic Recommendations - To achieve its goal of becoming a century-old brand, Mengjinyuan must address product quality, improve sales service, and enhance after-sales support [22]. - The company should focus on product innovation and digital marketing strategies to better engage with younger consumers and adapt to changing market dynamics [22].